Table 1 Characteristics of the study population: Spanish and foreign-born participants
Variables | Spanish n = 119 (%) | Foreign-born n = 83 (%) |
|---|---|---|
Age (Mean ± SD) | 39.9 ± 14.3 | 32.9 ± 19.9 |
Male (%) | 66 (55.5) | 46 (55.4) |
25 (OH)Vitamin D3 ng/ml (Mean ± SD) | 23.8 ± 13.8 | 23.68 ± 12.9 |
Vitamin 25 (OH)D3 ng/ml (Mean ± SD) Oct-March period | 19.5 ± 7.8 | 16.58 ± 7.41 |
Vitamin 25 (OH)D3 ng/ml (Mean ± SD) Apr-Sept period | 25.7 ± 15.5 | 28.86 ± 13.6 |
25 (OH)VitaminD3 levels | ||
0-19 ng/ml | 55 (46.2) | 34(41.0) |
20-29 ng/ml | 38 (31.9) | 34 (41.0) |
≥ 30 ng/ml | 26 (21.8) | 15 (18.0) |
Exposure to TB patient | ||
High | 35 (29.4) | 29(34.9) |
Medium | 51 (42.9) | 44 (53.0) |
Low | 33 (27.7) | 10 (12.1) |
High exposure and sputum AFB-positive index cases | 19 (15.9) | 21 (25.3) |
BCG vaccination | 36 (30.3) | 62 (74.7) |
Tuberculosis types | ||
Pulmonary TB sputum positive AFB smear | 81(68.1) | 74 (89.9) |
Pulmonary TB sputum positive culture M. tuberculosis | 28 (23.5) | 3 (3.6) |
Pleurisy | 7 (5.9) | 2 (2.4) |
Lymph node | 3 (2.5) | 4 (4.8) |
Foreign-born population | ||
Eastern Europe | 41 (49.4) | |
Maghreb | 13 (15.7) | |
Latin America | 29 (34.9) |